These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10630308)

  • 1. Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model.
    Hagenaars M; Ensink NG; Eggermont AM; van der Velde EA; van de Velde CJ; Fleuren GJ; Kuppen PJ
    Cancer Immunol Immunother; 2000 Jan; 48(10):561-8. PubMed ID: 10630308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
    Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
    J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats.
    Kuppen PJ; Basse PH; Goldfarb RH; Van De Velde CJ; Fleuren GJ; Eggermont AM
    Int J Cancer; 1994 Feb; 56(4):574-9. PubMed ID: 8112894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.
    Hallett WHD; Ames E; Álvarez M; Barao I; Taylor PA; Blazar BR; Murphy WJ
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1088-1099. PubMed ID: 18804038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antitumor activity of interleukin-2 and cimetidine against syngeneic murine tumor.
    Nakajima I; Chu TM
    Cancer Immunol Immunother; 1991; 33(1):9-14. PubMed ID: 2021961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: implications for the mechanism behind anti-tumor responses.
    Hagenaars M; Zwaveling S; Kuppen PJ; Ensink NG; Eggermont AM; Hokland ME; Basse PH; van de Velde CJ; Fleuren GJ; Nannmark U
    Int J Cancer; 1998 Dec; 78(6):783-9. PubMed ID: 9833773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine.
    Page GG; Ben-Eliyahu S; Liebeskind JC
    Brain Behav Immun; 1994 Sep; 8(3):241-50. PubMed ID: 7865895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of a bi-specific anti-CD161A x anti-tumor antibody for rat NK cell targeting.
    Hagenaars M; Ensink NG; Jonges LE; Chambers WH; Eggermont AM; van de Velde CJ; Fleuren GJ; Kuppen PJ
    Immunobiology; 1999 Feb; 200(1):31-48. PubMed ID: 10084694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of NKR-P1 is not an absolute requirement for natural killer activity in BDIX rats.
    Pinard D; Olsson NO; Chambers WH; Martin F
    Cancer Immunol Immunother; 1996 Jan; 42(1):15-23. PubMed ID: 8625362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium.
    Salvo G; Samoggia P; Masciulli R; Boccoli G; Allavena P; Mariani G; Bullo A; Montesoro E; Bulgarini D; Carlini P
    Eur J Cancer; 1992; 28A(4-5):818-25. PubMed ID: 1524901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells.
    Goding SR; Yang Q; Knudsen KB; Potter DM; Basse PH
    Hum Gene Ther; 2007 Aug; 18(8):701-11. PubMed ID: 17678438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.
    Tanaka N; Sivanandham M; Wallack MK
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):283-93. PubMed ID: 7881637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the antitumor activity of interleukin-12 in an experimental murine model of colorectal cancer induced by 1,2 dimethyl-hydrazine (DMH).
    Coca S; Enrech S; Moreno García V; Sáez MA; Gutiérrez C; Colmenarejo A; Hernández JM; Pérez Piqueras J
    Rev Esp Enferm Dig; 2005 Sep; 97(9):619-28. PubMed ID: 16266234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of natural killer cells with neutrophils exerts a significant antitumor immunity in hematopoietic stem cell transplantation recipients.
    Ueda R; Narumi K; Hashimoto H; Miyakawa R; Okusaka T; Aoki K
    Cancer Med; 2016 Jan; 5(1):49-60. PubMed ID: 26589884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination with genetically modified IL-2 secreting cells in a rat model of colonic carcinoma].
    Patry Y; Meflah K; Le Pendu J
    Bull Cancer; 1996 Mar; 83(3):218-26. PubMed ID: 8695924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration.
    Hagenaars M; Ensink NG; Koelemij R; Basse PH; Eggermont AM; van de Velde CJ; Fleuren GJ; Kuppen PJ
    Int J Cancer; 1998 Jan; 75(2):233-8. PubMed ID: 9462713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.